# q01 rev 2 - blind solver A (fresh blind-solver, packet solver-1), 2026-10-06

Raw return as received:

**answer:** Flat. At the closing in April 2026, the guidance in effect was from February 4, 2026. It called for fiscal 2026 adjusted operating income in "Other" to be flat, roughly 0% growth on the fiscal 2025 actual of $352M.

**confidence:** high

**path:**
1. **Closing date and the unit's group (D05, Q3 FY26 release, Aug 5, 2026).**
   - Line 81: "other businesses … have been grouped together in Other. These businesses include MWI Animal Health, Profarma, U.S. Consulting Services (which was divested in April 2026)…"
   - Line 95: "…due to the April 2026 divestiture of U.S. Consulting Services."
   - Footnote at line 269 repeats "divested in April 2026."
   - April 2026 falls inside fiscal 2026 (October 2025 to September 2026).
2. **The group was "Other" while the unit was held.**
   - D01 line 81 and D03 line 86 list "U.S. Consulting Services" among the businesses in Other.
   - D06 line 121 shows the regrouping that took effect October 1, 2025: Other "includes MWI Animal Health, Profarma, U.S. Consulting Services and the other components of PharmaLex."
   - Other "is not considered a reportable segment," which is why the question says "group of businesses."
3. **Guidance in effect in April 2026 (D01, Q1 FY26 release, Feb 4, 2026).**
   - The guidance table at line 114 (source doc line 115) reads "|Other(2)|Flat|$352M|".
   - This row sits under "Adjusted operating income | 11.5% to 13.5% growth." The $352M base confirms it is operating income; the Other revenue row is "1% to 5% growth | $8.2B."
   - Line 103 gives the reason: "improved results in Other as certain depreciable assets have been fully impaired as of December 31, 2025."
4. **No update between February 4 and the April closing.**
   - The next release, D03, is dated "May 6, 2026," after any April date.
   - D03 line 17 says EPS guidance was "raised from the previous range of $17.45 to $17.75," which is the D01 range.
   - D03 line 112 says the Other change happens in that update: "updated operating income expectations in Other as a result of MWI now being accounted for as 'held for sale'." Its new row (line 123) is "Other | High-single digit growth | $352M."
5. **Full trail for Other adjusted operating income guidance:**

| Release | Date | Guidance |
|---|---|---|
| D06 | Nov 5, 2025 | "1% to 4% decline" |
| D01 | Feb 4, 2026 | "Flat" (in effect at closing) |
| D03 | May 6, 2026 | "High-single digit growth" |
| D05 | Aug 5, 2026 | "~10% growth" |

   - D05 line 17 mentions an unseen interim EPS range ("previous range of $17.70 to $17.90"). That update must come after May 6, so it does not affect April.

No arithmetic was needed beyond placing the dates in order.

**minimal_documents:** D01 + D05.
- D05 is the only document that gives the closing date.
- D01 is the only document with the "Flat" figure.
- D03 is optional support showing the next update came on May 6, after the closing.
- No substitutes were found for D01 or D05.

**readings:**
- If "at the time of the closing" means the first guidance issued after the closing (D03, May 6, 2026): "High-single digit growth." This is weaker, because that guidance postdates April.
- The original fiscal 2026 guidance (D06, Nov 2025) was "1% to 4% decline," but D01 had replaced it before the closing.
- The latest guidance (D05, Aug 2026) is "~10% growth." It postdates the closing.
- Treating the group as U.S. Healthcare Solutions (the unit's home before October 1, 2025) would give "14% to 16% growth" in D01. That reading doesn't hold, because D01, D03 and D05 all place the unit in Other.

**gaps:**
- The exact closing day in April 2026 isn't stated. Any April date gives the same answer.
- The guidance update between May 6 and Aug 5, 2026 isn't in the packet. It is after the closing and doesn't matter here.
- D01's footnote says "Bolded figures indicate updates," but the bolding is lost in the text. The prose at D01 line 103 and D03 line 112 shows which releases changed the Other guidance.
- The documents are plain text (pages null, no layout files or PDFs), so there was no page image to check.
- I read D01, D03 and D05 only up to about line 160 and D06 lines 80–154; the rest of those files and all of D02/D04 (fiscal 2025 releases) were covered only by targeted searches ("consulting", divest/sold/closed, "April", held for sale/completed/subsequent). Those searches turned up no other relevant facts.

**contaminated:** no

Files used, all under D:\Dev\Docket\tasks\aq-01322\runs\q01-r2-v2-f103b326cdd8df6d9676a1e742d3af3146ddb82878a88e29225208cfa5deaee1\solver-1:
- text\D01.txt
- text\D03.txt
- text\D05.txt
- text\D06.txt
- text\manifest.json
- docs\cencora-inc-q1-fy2026-earnings-release-form-8-k-item-2-02-ex-99-1-filed-2026-02-04.txt
